SR-318

p38 MAP kinase inhibitor

Also Known As:

5-Amino-N-(4-((3-cyclohexylpropyl)carbamoyl)benzyl)-1-phenyl-1H-pyrazole-4-carboxamide

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Rheumatoid Arthritis 06/01/1988 - "[Double-blind evaluation of SR-318, a sustained release preparation of diclofenac sodium, on rheumatoid arthritis]."

1.	Diclofenac (SR 38)
2.	Delayed-Action Preparations